In a 17-year-old male with cystic fibrosis, which of the following statements is incorrect?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

The Incorrect Statement is D: Chronic Airway Colonization with Pneumococcus

Statement D is incorrect because cystic fibrosis patients characteristically develop chronic colonization with Pseudomonas aeruginosa and Staphylococcus aureus, not pneumococcus (Streptococcus pneumoniae).

Analysis of Each Statement

Statement A: Presence of 2 Mutations (1 from Each Parent) - CORRECT

Cystic fibrosis is an autosomal recessive disorder requiring biallelic CFTR mutations (one from each parent) for disease manifestation 1, 2. This is the fundamental genetic basis of CF.

Statement B: Elevated Sweat Chloride Concentration - CORRECT

Elevated sweat chloride is the diagnostic gold standard for CF. Levels >60 mmol/L are diagnostic 1. The CF Foundation guidelines reference sweat chloride testing as reflecting the basic defect in CF, with treated patients showing significant decreases in sweat chloride concentration 3.

Statement C: Cough, Dyspnea, and Wheezing - CORRECT

Respiratory symptoms are nearly universal in CF patients. Historical data shows that cough and sputum production occur in virtually all CF patients, with the first respiratory symptoms typically developing before age 5 in the vast majority of cases 4. These symptoms reflect the chronic lung disease that characterizes CF.

Statement D: Chronic Airway Colonization with Pneumococcus - INCORRECT

This is the key error. The characteristic pathogens in CF are:

  • Staphylococcus aureus (common early colonizer) 2
  • Pseudomonas aeruginosa (hallmark pathogen in CF) 3, 4, 5
  • Haemophilus influenzae 4
  • Nontuberculous mycobacteria (e.g., Mycobacterium abscessus) 2

The CF Foundation guidelines specifically address chronic management of P. aeruginosa colonization with inhaled tobramycin and azithromycin 3, emphasizing that persistent P. aeruginosa in airway cultures is the expected pattern requiring targeted therapy. The acquisition of mucoid Pseudomonas strains signifies poor prognosis 4.

Pneumococcus (Streptococcus pneumoniae) is NOT a characteristic colonizing organism in CF airways. While CF patients may occasionally develop pneumococcal infections like any other individual, chronic colonization with pneumococcus is not a recognized feature of CF pulmonary disease.

Clinical Pitfall

A common error is assuming all respiratory pathogens affect CF patients similarly to immunocompromised hosts. However, CF creates a unique airway environment that selectively favors specific organisms—particularly Pseudomonas aeruginosa—due to the thick, dehydrated mucus and impaired mucociliary clearance. Recognition of P. aeruginosa colonization should prompt consideration of CF diagnosis in adolescents and young adults with chronic lung disease 5.

Answer: D is the incorrect statement.

Related Questions

In a child with recurrent sinopulmonary infections, failure to thrive, and possible pancreatic insufficiency, what is the likelihood of cystic fibrosis and what is the next diagnostic step?
Can a 60-year-old adult develop cystic fibrosis?
In a hemodynamically stable, afebrile cystic fibrosis patient with a productive cough, purulent sputum, and a normal white blood cell count, what is the most appropriate next step in management?
What symptoms indicate a pulmonary flare in a patient with cystic fibrosis?
In an 18‑year‑old male with cystic fibrosis, mild obstructive disease on prior spirometry and current cough with yellow‑green sputum, which is the most appropriate next test to assess disease severity: arterial blood gas analysis, repeat spirometry, chest radiograph, or chest computed tomography?
In a 77‑year‑old man with new headache, photophobia, neck pain, altered mental status and a head CT that shows no mass effect or bleed, what is the appropriate next management?
What are the risks of general anesthesia during the second trimester of pregnancy?
Is topical niacinamide contraindicated in a patient taking a statin (HMG‑CoA reductase inhibitor)?
Is Vyvanse (lisdexamfetamine) used to treat erectile dysfunction?
Can a 10‑day‑old infant have diabetes insipidus?
In a patient whose anxiety improved after increasing escitalopram (Lexapro) to 20 mg daily and buspirone to 10 mg twice daily, but who still experiences anxiety and stress‑related nausea, what is the next appropriate medication step?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.